OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 01, 2022
FDA has accepted Ashland’s Viatel bioresorbable mPEG-PDLLA pharmaceutical excipient into the FDA Novel Excipient Review Pilot Program.
October 31, 2022
Roquette has launched excipients PEARLITOL CR-H and PEARLITOL 200 GT.
September 27, 2022
Roquette’s acquisition of Crest Cellulose is designed to reinforce its presence in India and other countries in Asia.
May 26, 2022
Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.
April 13, 2022
With high-concentration biologics, careful selection of excipients in formulation is crucial for reducing viscosity without destabilizing the protein.
March 24, 2022
Roquette is investing €25 million at its site in Lestrem, France to strengthen its position in the polyols market.
March 02, 2022
Careful selection is essential for achieving viscosity reduction without protein destabilization.
August 02, 2021
Advances in technology are accelerating the development and manufacture of subunit vaccines, an established class of vaccines.
June 02, 2021
Contract manufacturers play a key role in the production of lipid nanoparticles for RNA vaccines.
April 22, 2021
DFE’s new line will offer market purity and low endotoxin excipients for use in formulation, while providing drug developers and manufacturers high-quality excipient technology and services.